| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Report |
From the Cardiovascular Division (F.M., O.P., M.J., A.O., S.N., R.L.), Department of Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston; and The Pulmonary Center (R.S., A.F.), Boston University School of Medicine, Mass.
Correspondence to Dr Ronglih Liao, Cardiovascular Division, Department of Medicine, Brigham and Womens Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, NRB 431, Boston, MA 02115. E-mail rliao{at}rics.bwh.harvard.edu
Tissue-specific progenitor cells contribute to local cellular regeneration and maintain organ function. Recently, we have determined that cardiac side-population (CSP) cells represent a distinct cardiac progenitor cell population, capable of in vitro differentiation into functional cardiomyocytes. The response of endogenous CSP to myocardial injury, however, and the cellular mechanisms that maintain this cardiac progenitor cell pool in vivo remain unknown. In this report we demonstrate that local progenitor cell proliferation maintains CSP under physiologic conditions, with little contribution from extracardiac stem cell sources. Following myocardial infarction in adult mice, however, CSP cells are acutely depleted, both within the infarct and noninfarct areas. CSP pools are subsequently reconstituted to baseline levels within 7 days after myocardial infarction, through both proliferation of resident CSP cells, as well as through homing of bone marrowderived stem cells (BMC) to specific areas of myocardial injury and immunophenotypic conversion of BMC to adopt a CSP phenotype. We, therefore, conclude that following myocardial injury, cardiac progenitor cell populations are acutely depleted and are reconstituted to normal levels by both self-proliferation and selective homing of BMC. Understanding and enhancing such processes hold enormous potential for therapeutic myocardial regeneration.
Key Words: side population cells cardiac progenitor cells myocardial infarction cardiomyogenesis
This article has been cited by other articles:
![]() |
S. C. Kolwicz, S. M. MacDonnell, B. F. Renna, P. O. Reger, R. Seqqat, K. Rafiq, Z. V. Kendrick, S. R. Houser, A. Sabri, and J. R. Libonati Left ventricular remodeling with exercise in hypertension Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1361 - H1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Boudoulas and A. K. Hatzopoulos Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease Dis. Model. Mech., July 1, 2009; 2(7-8): 344 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stamm, Y.-H. Choi, B. Nasseri, and R. Hetzer A heart full of stem cells: the spectrum of myocardial progenitor cells in the postnatal heart Therapeutic Advances in Cardiovascular Disease, June 1, 2009; 3(3): 215 - 229. [Abstract] [PDF] |
||||
![]() |
Y. L. Tang, W. Zhu, M. Cheng, L. Chen, J. Zhang, T. Sun, R. Kishore, M. I. Phillips, D. W. Losordo, and G. Qin Hypoxic Preconditioning Enhances the Benefit of Cardiac Progenitor Cell Therapy for Treatment of Myocardial Infarction by Inducing CXCR4 Expression Circ. Res., May 22, 2009; 104(10): 1209 - 1216. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Reinecke, E. Minami, W.-Z. Zhu, and M. A. Laflamme Cardiogenic Differentiation and Transdifferentiation of Progenitor Cells Circ. Res., November 7, 2008; 103(10): 1058 - 1071. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Pfister, A. Oikonomopoulos, K.-I. Sereti, R. L. Sohn, D. Cullen, G. C. Fine, F. Mouquet, K. Westerman, and R. Liao Role of the ATP-Binding Cassette Transporter Abcg2 in the Phenotype and Function of Cardiac Side Population Cells Circ. Res., October 10, 2008; 103(8): 825 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kubo, N. Jaleel, A. Kumarapeli, R. M. Berretta, G. Bratinov, X. Shan, H. Wang, S. R. Houser, and K. B. Margulies Increased Cardiac Myocyte Progenitors in Failing Human Hearts Circulation, August 5, 2008; 118(6): 649 - 657. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dimmeler and A. Leri Aging and Disease as Modifiers of Efficacy of Cell Therapy Circ. Res., June 6, 2008; 102(11): 1319 - 1330. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Pfister and R. Liao Pump to Survive: Novel Cytoprotective Strategies for Cardiac Progenitor Cells Circ. Res., May 9, 2008; 102(9): 998 - 1001. [Full Text] [PDF] |
||||
![]() |
S. Scobioala, R. Klocke, M. Kuhlmann, W. Tian, L. Hasib, H. Milting, S. Koenig, M. Stelljes, A. El-Banayosy, G. Tenderich, et al. Up-regulation of nestin in the infarcted myocardium potentially indicates differentiation of resident cardiac stem cells into various lineages including cardiomyocytes FASEB J, April 1, 2008; 22(4): 1021 - 1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Spees, M. J. Whitney, D. E. Sullivan, J. A. Lasky, M. Laboy, J. Ylostalo, and D. J. Prockop Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension FASEB J, April 1, 2008; 22(4): 1226 - 1236. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tillmanns, M. Rota, T. Hosoda, Y. Misao, G. Esposito, A. Gonzalez, S. Vitale, C. Parolin, S. Yasuzawa-Amano, J. Muraski, et al. Formation of large coronary arteries by cardiac progenitor cells PNAS, February 5, 2008; 105(5): 1668 - 1673. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dimmeler, J. Burchfield, and A. M. Zeiher Cell-Based Therapy of Myocardial Infarction Arterioscler Thromb Vasc Biol, February 1, 2008; 28(2): 208 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Ellison, D. Torella, I. Karakikes, S. Purushothaman, A. Curcio, C. Gasparri, C. Indolfi, N. T. Cable, D. F. Goldspink, and B. Nadal-Ginard Acute beta-Adrenergic Overload Produces Myocyte Damage through Calcium Leakage from the Ryanodine Receptor 2 but Spares Cardiac Stem Cells J. Biol. Chem., April 13, 2007; 282(15): 11397 - 11409. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Shantsila, T. Watson, and G. Y.H. Lip Endothelial Progenitor Cells in Cardiovascular Disorders J. Am. Coll. Cardiol., February 20, 2007; 49(7): 741 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lehrke, R. Mazhari, D. J. Durand, M. Zheng, D. Bedja, J. M. Zimmet, K. H. Schuleri, A. S. Chi, K. L. Gabrielson, and J. M. Hare Aging Impairs the Beneficial Effect of Granulocyte Colony-Stimulating Factor and Stem Cell Factor on Post-Myocardial Infarction Remodeling Circ. Res., September 1, 2006; 99(5): 553 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Boyle, S. P. Schulman, and J. M. Hare Stem Cell Therapy for Cardiac Repair: Ready for the Next Step Circulation, July 25, 2006; 114(4): 339 - 352. [Full Text] [PDF] |
||||
![]() |
H. Okuyama, B. Krishnamachary, Y. F. Zhou, H. Nagasawa, M. Bosch-Marce, and G. L. Semenza Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1 J. Biol. Chem., June 2, 2006; 281(22): 15554 - 15563. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Thum, D. Fraccarollo, P. Galuppo, D. Tsikas, S. Frantz, G. Ertl, and J. Bauersachs Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells Cardiovasc Res, April 1, 2006; 70(1): 50 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Anversa, J. Kajstura, A. Leri, and R. Bolli Life and Death of Cardiac Stem Cells: A Paradigm Shift in Cardiac Biology Circulation, March 21, 2006; 113(11): 1451 - 1463. [Full Text] [PDF] |
||||
![]() |
B. Dawn and R. Bolli Cardiac Progenitor Cells: The Revolution Continues Circ. Res., November 25, 2005; 97(11): 1080 - 1082. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |